• Türkçe
    • English
  • Türkçe 
    • Türkçe
    • English
  • Giriş
Öğe Göster 
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • PubMed İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • PubMed İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
JavaScript is disabled for your browser. Some features of this site may not work without it.

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

Göster/Aç

Full Text / Tam Metin (1.005Mb)

Erişim

info:eu-repo/semantics/closedAccess

Tarih

2023

Yazar

Younossi, Zobair M.
Alqahtani, Saleh A.
Alswat, Khalid
Yılmaz, Yusuf
Keklikkıran, Çağlayan
Funuyet-Salas, Jesús
Romero-Gómez, Manuel
Fan, Jian-Gao
Zheng, Ming-Hua
El-Kassas, Mohamed
Castera, Laurent
Liu, Chun-Jen
Wai-Sun Wong, Vincent
Zelber-Sagi, Shira
Allen, Alina M.
Lam, Brian
Treeprasertsuk, Sombat
Hameed, Saeed
Takahashi, Hirokazu
Kawaguchi, Takumi
Schattenberg, Jörn M.
Duseja, Ajay
Newsome, Phil N.
Francque, Sven
Spearman, C. Wendy
Castellanos Fernández, Marlen I.
Burra, Patrizia
Roberts, Stuart K.
Chan, Wah-Kheong
Arrese, Marco
Silva, Marcelo
Rinella, Mary
Singal, Ashwani K.
Gordon, Stuart
Fuchs, Michael
Alkhouri, Naim
Cusi, Kenneth
Loomba, Rohit
Ranagan, Jane
Eskridge, Wayne
Kautz, Achim
Ong, Janus P.
Kugelmas, Marcelo
Eguchi, Yuichiro
Diago, Moises
Yu, Ming-Lung
Gerber, Lynn
Fornaresio, Lisa
Nader, Fatema
Henry, Linda
Racila, Andrei
Golabi, Pegah
Stepanova, Maria
Carrieri, Patrizia
Lazarus, Jeffrey V.

Üst veri

Tüm öğe kaydını göster

Künye

Younossi, Z. M., Alqahtani, S. A., Alswat, K., Yilmaz, Y., Keklikkiran, C., Funuyet-Salas, J., Romero-Gómez, M., Fan, J. G., Zheng, M. H., El-Kassas, M., Castera, L., Liu, C. J., Wai-Sun Wong, V., Zelber-Sagi, S., Allen, A. M., Lam, B., Treeprasertsuk, S., Hameed, S., Takahashi, H., Kawaguchi, T., … Global NASH Council (2023). Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. Journal of hepatology, S0168-8278(23)05279-0. Advance online publication. https://doi.org/10.1016/j.jhep.2023.11.004

Özet

Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this crosssectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and healthcare providers. Methods: Members of the Global NASH Council created two surveys about experiences/attitudes toward NAFLD and related diagnostic terms: a 68-item patient and a 41-item provider survey. Results: Surveys were completed by 1,976 patients with NAFLD across 23 countries (51% Middle East/North Africa [MENA], 19% Europe, 17% USA, 8% Southeast Asia, 5% South Asia) and 825 healthcare providers (67% gastroenterologists/hepatologists) across 25 countries (39% MENA, 28% Southeast Asia, 22% USA, 6% South Asia, 3% Europe). Of all patients, 48% ever disclosed having NAFLD/NASH to family/friends; the most commonly used term was “fatty liver” (88% at least sometimes); “metabolic disease” or “MAFLD” were rarely used (never by >84%). Regarding various perceptions of diagnostic terms by patients, there were no substantial differences between “NAFLD”, “fatty liver disease (FLD)”, “NASH”, or “MAFLD”. The most popular response was being neither comfortable nor uncomfortable with either term (56%-71%), with slightly greater discomfort with “FLD” among the US and South Asian patients (47-52% uncomfortable). Although 26% of patients reported stigma related to overweight/obesity, only 8% reported a history of stigmatization or discrimination due to NAFLD. Among providers, 38% believed that the term “fatty” was stigmatizing, while 34% believed that “nonalcoholic” was stigmatizing, more commonly in MENA (43%); 42% providers (gastroenterologists/hepatologists 45% vs. 37% other specialties, p = 0.03) believed that the name change to metabolic dysfunction-associated steatotic liver disease (or MASLD) might reduce stigma. Regarding the new nomenclature, the percentage of providers reporting “steatotic liver disease” as stigmatizing was low (14%). Conclusions: The perception of NAFLD stigma varies among patients, providers, geographic locations and sub-specialties.

Kaynak

Journal of Hepatology

Bağlantı

https://doi.org/10.1016/j.jhep.2023.11.004
https://hdl.handle.net/11436/8695

Koleksiyonlar

  • PubMed İndeksli Yayınlar Koleksiyonu [2443]
  • Scopus İndeksli Yayınlar Koleksiyonu [5931]
  • TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu [1559]



DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 




| Yönerge | Rehber | İletişim |

DSpace@RTEÜ

by OpenAIRE
Gelişmiş Arama

sherpa/romeo

Göz at

Tüm DSpaceBölümler & KoleksiyonlarTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına GöreBu KoleksiyonTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına Göre

Hesabım

GirişKayıt

İstatistikler

Google Analitik İstatistiklerini Görüntüle

DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 


|| Rehber|| Yönerge || Kütüphane || Recep Tayyip Erdoğan Üniversitesi || OAI-PMH ||

Recep Tayyip Erdoğan Üniversitesi, Rize, Türkiye
İçerikte herhangi bir hata görürseniz, lütfen bildiriniz:

Creative Commons License
Recep Tayyip Erdoğan Üniversitesi Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@RTEÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.